22:18 , Oct 11, 2017 |  BC Extra  |  Preclinical News

Team identifies HIF2A as liver disease target

A paper published in Nature Medicine by researchers at the National Cancer Institute and colleagues identified intestinal endothelial PAS domain protein 1 ( HIF2A ; HIF-2alpha ; EPAS1) as a promising target to treat hepatic...
08:00 , Dec 20, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Renal cell carcinoma (RCC) Sialidase 3 (NEU3; SIAL3) Studies in cell culture suggest antagonizing NEU3 could help treat RCC. In cultured...